Avicenna.AI

By Avicenna.AI
· France
Avicenna.AI — CT detection across stroke, pulmonary embolism and aortic pathology.
Diagnostic
Radiology
Production
CE Marked
Regulatory status
CE Marked
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
France
AI type
Diagnostic

Precise indication

CT detection across stroke, pulmonary embolism and aortic pathology.

Regulatory status

CE marked; multiple indications under one CE-marked platform.

Clinical evidence

Vendor-supported

Distribution partner (deepc) announcement of the partnership.

Independent

Not found in this research pass — verify before publishing.

Real-world deployment

Distributed notably through the contextflow/deepc platform; no independent site count found.

Interoperability

European status

Editorial verdict

Limits and uncertainties

Deployment scale not independently quantified in this pass.

Sources

https://www.deepc.ai/news/deepc-strengthens-radiology-ai-portfolio-with-ipe-detection-from-avicenna-made-available-through-contextflow

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
Avicenna.AI
Headquarters
France
AI type
Diagnostic
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.